We gratefully acknowledge support from
the Simons Foundation and member institutions.
Full-text links:

Download:

Current browse context:

q-bio.TO

Change to browse by:

References & Citations

Bookmark

(what is this?)
CiteULike logo BibSonomy logo Mendeley logo del.icio.us logo Digg logo Reddit logo ScienceWISE logo

Quantitative Biology > Tissues and Organs

Title: Maximum Tolerated Dose Versus Metronomic Scheduling in the Treatment of Metastatic Cancers

Authors: Sebastien Benzekry (CCSB), Philip Hahnfeldt (CCSB)
Abstract: Although optimal control theory has been used for the theoretical study of anti-cancerous drugs scheduling optimization, with the aim of reducing the primary tumor volume, the effect on metastases is often ignored. Here, we use a previously published model for metastatic development to define an optimal control problem at the scale of the entire organism of the patient. In silico study of the impact of different scheduling strategies for anti-angiogenic and cytotoxic agents (either in monotherapy or in combination) is performed to compare a low-dose, continuous, metronomic administration scheme with a more classical maximum tolerated dose schedule. Simulation results reveal differences between primary tumor reduction and control of metastases but overall suggest use of the metronomic protocol.
Subjects: Tissues and Organs (q-bio.TO); Analysis of PDEs (math.AP)
Cite as: arXiv:1306.4842 [q-bio.TO]
  (or arXiv:1306.4842v1 [q-bio.TO] for this version)

Submission history

From: Sebastien Benzekry [view email]
[v1] Thu, 20 Jun 2013 12:08:17 GMT (4674kb)

Link back to: arXiv, form interface, contact.